Combination of convalescent plasma therapy and repurposed drugs to treat severe COVID‐19 patient with multimorbidity

Abstract

Abstract Combination of convalescent plasma therapy and repurposed drugs such as dexamethasone and remdesivir could be beneficial for severe COVID‐19 patients with obesity and chronic diseases such as diabetes and hypertension.

Keywords

• convalescent plasma therapy
• COVID‐19 infection
• multimorbidity
• Nepal